These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 11483633)
1. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. Navab M; Hama SY; Hough GP; Subbanagounder G; Reddy ST; Fogelman AM J Lipid Res; 2001 Aug; 42(8):1308-17. PubMed ID: 11483633 [TBL] [Abstract][Full Text] [Related]
2. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659 [TBL] [Abstract][Full Text] [Related]
4. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. Navab M; Hama SY; Cooke CJ; Anantharamaiah GM; Chaddha M; Jin L; Subbanagounder G; Faull KF; Reddy ST; Miller NE; Fogelman AM J Lipid Res; 2000 Sep; 41(9):1481-94. PubMed ID: 10974056 [TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. Reddy S; Hama S; Grijalva V; Hassan K; Mottahedeh R; Hough G; Wadleigh DJ; Navab M; Fogelman AM J Biol Chem; 2001 May; 276(20):17030-5. PubMed ID: 11278958 [TBL] [Abstract][Full Text] [Related]
6. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. Watson AD; Leitinger N; Navab M; Faull KF; Hörkkö S; Witztum JL; Palinski W; Schwenke D; Salomon RG; Sha W; Subbanagounder G; Fogelman AM; Berliner JA J Biol Chem; 1997 May; 272(21):13597-607. PubMed ID: 9153208 [TBL] [Abstract][Full Text] [Related]
7. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782 [TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Gharavi NM; Gargalovic PS; Chang I; Araujo JA; Clark MJ; Szeto WL; Watson AD; Lusis AJ; Berliner JA Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1346-53. PubMed ID: 17379837 [TBL] [Abstract][Full Text] [Related]
10. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833 [TBL] [Abstract][Full Text] [Related]
11. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211 [TBL] [Abstract][Full Text] [Related]
12. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes. Mastorikou M; Mackness M; Mackness B Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348 [TBL] [Abstract][Full Text] [Related]
13. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446 [TBL] [Abstract][Full Text] [Related]
14. Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages. Girona J; La Ville AE; Heras M; Olivé S; Masana L Free Radic Biol Med; 1997; 23(4):658-67. PubMed ID: 9215811 [TBL] [Abstract][Full Text] [Related]
15. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. Yan D; Navab M; Bruce C; Fogelman AM; Jiang XC J Lipid Res; 2004 Oct; 45(10):1852-8. PubMed ID: 15258196 [TBL] [Abstract][Full Text] [Related]
16. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. Gharavi NM; Alva JA; Mouillesseaux KP; Lai C; Yeh M; Yeung W; Johnson J; Szeto WL; Hong L; Fishbein M; Wei L; Pfeffer LM; Berliner JA J Biol Chem; 2007 Oct; 282(43):31460-8. PubMed ID: 17726017 [TBL] [Abstract][Full Text] [Related]
17. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Lee H; Shi W; Tontonoz P; Wang S; Subbanagounder G; Hedrick CC; Hama S; Borromeo C; Evans RM; Berliner JA; Nagy L Circ Res; 2000 Sep; 87(6):516-21. PubMed ID: 10988245 [TBL] [Abstract][Full Text] [Related]
18. Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. Folcik VA; Cathcart MK J Lipid Res; 1994 Sep; 35(9):1570-82. PubMed ID: 7806971 [TBL] [Abstract][Full Text] [Related]